Heavyweight document release, future equipment demand or further expansion

Pharmaceutical Network Market Analysis" Recently, the three departments of the State issued the "Public Health Prevention and Control Capacity Building Program", the plan put forward five major construction tasks: strengthening the modernization of the disease prevention and control system;with the promotion of these five construction tasks, the industry believes that some laboratory-related equipment including biosafety cabinets, ventilation systems, high-precision testing experimental equipment and other requirements are expected to continue to increase, in addition to ICU-related equipment including monitors, suction machines, infusion pumps, portable ultrasound, blood gas analyzers and other medical equipment is also expected to be configured in accordance with the proportion of clinical needs, there will be further expansion of the demand in the futurethese devices are closely related to five construction tasks, such as biosafety cabinets, which are box-type air purification negative pressure safety devices that can prevent the occurrence of aerosol dispersion in certain hazardous or unknown biological particles during experimental operation and processing, and are also protective barriers for researchersIt is widely used in microbiology, biomedical, genetic engineering, biological products and other fields of scientific research, teaching, clinical testing and production, is the laboratory biosecurity in the first level of protection barrier basic safety protection equipmentAccording to NSF49 standard, biosafety cabinets are classified as I, II, III, and can be applied to the operation of different biosafety grade mediarespirator is a medical device that can prevent and treat respiratory failure, reduce complications, save and prolong a patient's life, and is now widely used in the field of modern medicine for respiratory failure due to various causes, anaesthetic respiratory management during major surgery, respiratory support therapy and emergency resuscitationcombined with the current situation and the performance of enterprises in various fields, securities sources recommend edgtos: biosafety cabinet: Haier Biology; Monitoring and life support equipment: Murray Medical; Respiratory Machines, etc.: Fish Leap Medical; Testing: Wanfu Bio, Antu Bio, Mike Bio, New Industries, etcHaier Bio's quarterly report on the evening of April 28 showed that the company achieved operating income of 267 million yuan and net profit attributable to shareholders of listed companies of 69.2785 million yuan, up 32.74 percent and 141.42 percent, respectively, year-on-yearIn the first quarter, Haier bio-safety cabinets, ultra-low temperature equipment and other company's main products showed explosive growthThe quarterly report shows that the overall growth of the domestic market during the reporting period was steady, with revenue up 20.2% YoY, with the growth of biosafety cabinet products particularly significant, with revenue up 127% YoYin mid-April this year, the main medical device products of Fish Leap Medical released the first quarter of 2020 and 2019 full-year financial resultsAccording to financial reports, Fish Leap Medical achieved total revenue of Rmb1,391m in the first quarter of this year, up 15.8% YoY, and net profit of Rmb383m, up 55.16% YoYFish Leap Medical because of the production of ventilators, infrared temperature guns and other products, by the capital market crazy pursuit, since 2020 share price rose more than 55%, the total market value of more than 30 billion yuanMurray Healthcare achieved revenue of RMB4,741 million, up 21.39% YoY, and net profit of 1.313 billion yuan, up 30.60% YoYThe 2020 quarterly report shows that in the first quarter, its life information and support line monitor, ventilator, infusion pump high-speed growth, the overall estimated growth rate of more than 50%;